Efficacy, durability, and tolerability of dolutegravir/lamivudine and dolutegravir/rilpivirine for the treatment of HIV in a real‐world setting in Belgium

Objectives A paradigm shift from three‐drug regimens to two‐drug regimens (2DRs) is currently taking place in real‐world clinical practice. This study aimed to describe the efficacy, durability, and tolerability of dolutegravir (DTG)/lamivudine (3TC) and DTG/rilpivirine (RPV) in a real‐world setting...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	HIV medicine 2023-03, Vol.24 (3), p.267-278
Hauptverfasser:	Nasreddine, Rakan, Yombi, Jean Cyr, Darcis, Gilles, Florence, Eric, Allard, Sabine D., De Scheerder, Marie‐Angélique, Henrard, Sophie, Demeester, Rémy, Messiaen, Peter, Ausselet, Nathalie, Loeckx, Matthias, Delforge, Marc, De Wit, Stéphane
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anti-HIV Agents - therapeutic use Belgium Confidence intervals dolutegravir/lamivudine dolutegravir/rilpivirine Durability Effectiveness Female Heterocyclic Compounds, 3-Ring - therapeutic use HIV HIV Infections - drug therapy Human immunodeficiency virus Humans Lamivudine Lamivudine - therapeutic use Load distribution Male Neurotoxicity Oxazines - therapeutic use real‐world data Regression analysis Rilpivirine Statistical analysis Tenofovir virological suppression Weight
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!